​​​​ATTIRE Randomised Clinical Trial

Feasibility Study

There is no follow up for the feasibility study. Once the patient has reached the end of the trial treatment period (Day 14 or discharge) no further data will be collected apart from SAE outcomes. 


There will be 2 follow up episodes in the RCT at 3 and 6 months post discharge. Clinical, biochemical and quality of life data will be collected.